PIK3CA and head and neck squamous cell carcinoma: Based on our experience with other small molecule inhibitors, where we have observed a heterogeneous response to the drug, we hypothesized that HNSCC models would also exhibit heterogeneity with respect to the effect of PI3K inhibitors.